主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CUE
#3645
Cue Biopharma, Inc.
0.2
8
0.00%
版块:
基础:
利润货币:
日范围
年范围
日变化
0.00%
每月变动
-26.32%
6个月变化
-65.85%
年变化
-76.47%
前一天收盘价
0.2
8
Open
0.2
8
Bid
Ask
Low
0.2
8
High
0.2
8
交易量
6
市场
股票
医疗保健
CUE
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
30.46 M
33.01 M
43.17 M
48.64 M
61.82 M
—
Valuation ratios
Enterprise value
306.15 M
308.98 M
71.32 M
90.95 M
44.96 M
170.83 M
Price to earnings ratio
—
—
-1.79
-2.5
-1.51
-5.9
Price to sales ratio
—
—
178.44
18.89
6.09
24.43
Price to cash flow ratio
—
—
-2.27
-3.18
-1.69
-6.49
Price to book ratio
—
—
1.44
3.43
3.51
5.82
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.45
-0.53
-0.58
0.82
1.26
1.29
Return on equity %
-0.57
-0.67
-0.81
1.37
2.32
3.43
Return on invested capital %
-849.98
-804.24
-1 067.99
—
952.32
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 427.96
-292.56
-10.02 K
774.3
411.58
3 427.21
EBITDA margin %
—
—
—
—
—
—
Net margin %
-1 419.79
-295.56
-9 975.38
753.27
403.39
3 399.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.36
5.35
6.68
3.01
1.84
6.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.16
0.01
0.09
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
0.09
0.07
0
0.02
Debt to equity ratio
—
—
0.12
0.11
0
0.03
Long term debt to total assets ratio
—
—
0.09
0.07
0
0
Long term debt to total equity ratio
—
—
0.12
0.11
0
0
Per share metrics
Operating cash flow per share
—
—
-1.17
0.87
0.64
0.4
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
0.23
0.09
0
0.01
Cash per share
—
—
2.14
1.06
0.4
1.05
Net current asset value per share
—
—
2.17
1.12
0.45
1.24
Tangible book value per share
—
—
1.84
0.81
0.31
0.72
Working capital per share
—
—
1.84
0.75
0.2
0.43
Book value per share
—
—
1.84
0.81
0.31
0.72
新闻
Cue Biopharma以每股0.28美元定价1000万美元公开发行
Cue Biopharma prices $10 million public offering at $0.28 per share
Cue Biopharma股价因公开发行公告暴跌
Cue Biopharma stock tumbles on public offering announcement
Cue Biopharma启动普通股和权证公开发行
Cue Biopharma launches public offering of common stock and warrants
Cue Biopharma股票评级被Citizens重申为"市场表现优于大盘"
Cue Biopharma stock rating reiterated at Market Outperform by Citizens
ImmunoScape获得Cue Biopharma技术许可开发新型癌症疗法
ImmunoScape licenses Cue Biopharma technology for novel cancer therapy
Cue Biopharma Q3 每股收益 超出预期, 营收 低于预期
Cue Biopharma earnings beat by $0.02, revenue fell short of estimates